Sherer Y - Search Results

1

Autoantibodies to oxidized low-density lipoprotein in coronary artery disease.

Sherer Y, Tenenbaum A, Blank M, Shemesh J, Harats D, Fisman EZ, Praprotnik S, Motro M, Shoenfeld Y. Sherer Y, et al. Am J Hypertens. 2001 Feb;14(2):149-54. doi: 10.1016/s0895-7061(00)01242-5. Am J Hypertens. 2001. PMID: 11243306

2

Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension.

Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Motro M, Shoenfeld Y. Sherer Y, et al. Cardiology. 2002;97(1):2-5. doi: 10.1159/000047411. Cardiology. 2002. PMID: 11893822

3

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain.

Sherer Y, Shemesh J, Tenenbaum A, Praprotnik S, Harats D, Fisman EZ, Blank M, Motro M, Shoenfeld Y. Sherer Y, et al. Am J Cardiol. 2000 Dec 15;86(12):1306-11. doi: 10.1016/s0002-9149(00)01232-7. Am J Cardiol. 2000. PMID: 11113403

4

Autoantibodies associated with atherosclerosis.

Shoenfeld Y, Sherer Y, George J, Harats D. Shoenfeld Y, et al. Among authors: sherer y. Ann Med. 2000 Dec;32 Suppl 1:37-40. Ann Med. 2000. PMID: 11209980 Review.

5

Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies.

Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Harats D, George J, Levy Y, Peter JB, Motro M, Shoenfeld Y. Sherer Y, et al. Cardiology. 2001;95(1):20-4. doi: 10.1159/000047338. Cardiology. 2001. PMID: 11385187

6

Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?

Sherer Y, Shoenfeld Y. Sherer Y, et al. Immunobiology. 2003;207(1):13-6. doi: 10.1078/0171-2985-00212. Immunobiology. 2003. PMID: 12638897 Review.

7

Functional class in patients with heart failure is associated with the development of diabetes.

Tenenbaum A, Motro M, Fisman EZ, Leor J, Freimark D, Boyko V, Mandelzweig L, Adler Y, Sherer Y, Behar S. Tenenbaum A, et al. Among authors: sherer y. Am J Med. 2003 Mar;114(4):271-5. doi: 10.1016/s0002-9343(02)01530-9. Am J Med. 2003. PMID: 12681453

8

Aortic valve calcification in hypertensive patients: prevalence, risk factors and association with transvalvular flow velocity.

Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Shemesh J, Sherer Y, Motro M. Tenenbaum A, et al. Among authors: sherer y. Int J Cardiol. 2004 Mar;94(1):7-13. doi: 10.1016/j.ijcard.2003.02.004. Int J Cardiol. 2004. PMID: 14996468

9

Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up.

Fisman EZ, Motro M, Tenenbaum A, Leor J, Boyko V, Mandelzweig L, Sherer Y, Adler Y, Behar S. Fisman EZ, et al. Among authors: sherer y. Eur J Cardiovasc Prev Rehabil. 2004 Apr;11(2):135-43. doi: 10.1097/01.hjr.0000124326.85096.ec. Eur J Cardiovasc Prev Rehabil. 2004. PMID: 15187817

10

Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.

Sherer Y, Gerli R, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y. Sherer Y, et al. Ann N Y Acad Sci. 2005 Jun;1051:299-303. doi: 10.1196/annals.1361.071. Ann N Y Acad Sci. 2005. PMID: 16126971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters